Cochlear | COH - Operating Profit


Cochlear reported AUD261.1M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Fisher Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Mesoblast USD -30.96M 11.14M Dec/2025
Monash IVF AUD 18M 10.11M Dec/2025
Nanosonics AUD 9.12M 3.82M Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
Regis Healthcare AUD 24.67M 11.91M Dec/2025
ResMed USD 499.81M 490K Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Somnomed AUD -4.16M 1.28M Jun/2023
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026